| Celcuity Inc. | 501K | US$52.4M | 5.4% |
| Cogent Biosciences, Inc. | 1.28M | US$49.6M | 5.2% |
| Immunome, Inc. | 2.02M | US$42.7M | 4.4% |
| Dianthus Therapeutics, Inc. | 390K | US$38M | 4.0% |
| Rhythm Pharmaceuticals, Inc. | 311K | US$34.6M | 3.6% |
| Oruka Therapeutics, Inc. | 353K | US$33.6M | 3.5% |
| Monte Rosa Therapeutics, Inc. | 1.11M | US$26.8M | 2.8% |
| Syndax Pharmaceuticals, Inc. | 1.21M | US$26.5M | 2.8% |
| Enliven Therapeutics, Inc. | 489K | US$24.8M | 2.6% |
| Immunovant, Inc. | 619K | US$23.9M | 2.5% |
| Erasca, Inc. | 1.26M | US$23.1M | 2.4% |
| Sagimet Biosciences Inc. - Series A | 2.93M | US$22.6M | 2.4% |
| Abivax Sa | 170K | US$22.6M | 2.3% |
| Praxis Precision Medicines, Inc. | 65,679 | US$22M | 2.3% |
| Kodiak Sciences Inc | 546K | US$21.3M | 2.2% |
| Definium Therapeutics, Inc. | 400K | US$18.8M | 2.0% |
| Veracyte, Inc. | 318K | US$18.7M | 1.9% |
| Guardant Health, Inc. | 99,826 | US$15M | 1.6% |
| C4 Therapeutics, Inc. | 3.03M | US$14.2M | 1.5% |
| Zenas Biopharma, Inc. | 510K | US$12.9M | 1.3% |
| Trevi Therapeutics, Inc. | 678K | US$12.6M | 1.3% |
| Helix Acquisition Corp. Iii | 1.18M | US$12.5M | 1.3% |
| Alx Oncology Holdings Inc. | 5.74M | US$11.9M | 1.2% |
| Veradermics, Incorporated | 95,000 | US$11.7M | 1.2% |
| Xenon Pharmaceuticals Inc. | 187K | US$11.3M | 1.2% |
| Avalyn Pharma Inc. | 330K | US$10.9M | 1.1% |
| Biogen Inc. | 48,101 | US$10.4M | 1.1% |
| Aclaris Therapeutics, Inc. | 1.95M | US$10.3M | 1.1% |
| Cerus Corporation | 3.47M | US$10.1M | 1.1% |
| Avalo Therapeutics, Inc. | 500K | US$9.25M | 0.96% |
| Benitec Biopharma Inc. | 680K | US$9.1M | 0.95% |
| Vaxcyte, Inc. | 145K | US$8.43M | 0.88% |
| Genedx Holdings Corp. | 122K | US$8.39M | 0.87% |
| Savara, Inc. | 1.36M | US$8.35M | 0.87% |
| Ovid Therapeutics Inc. | 3.1M | US$8.34M | 0.87% |
| Oric Pharmaceuticals, Inc. | 739K | US$8M | 0.83% |
| Solid Biosciences Inc. | 668K | US$6.68M | 0.69% |
| Ibio, Inc. | 3.52M | US$6.16M | 0.64% |
| Disc Medicine, Inc. | 82,800 | US$6.06M | 0.63% |
| Spyre Therapeutics, Inc. | 59,959 | US$5.32M | 0.55% |
| Artiva Biotherapeutics, Inc. | 525K | US$5.09M | 0.53% |
| Contineum Therapeutics, Inc. | 296K | US$4.85M | 0.50% |
| Research Alliance Corporation Iii | 360K | US$3.85M | 0.40% |
| Abeona Therapeutics Inc. | 610K | US$3.77M | 0.39% |
| Insmed Incorporated | 34,438 | US$3.67M | 0.38% |
| Karyopharm Therapeutics Inc. | 297K | US$2.91M | 0.30% |
| Camp4 Therapeutics Corporation | 654K | US$2.86M | 0.30% |
| Elutia, Inc. | 2.19M | US$2.15M | 0.22% |
| Revolution Medicines, Inc. | 10,000 | US$1.87M | 0.19% |
| Sionna Therapeutics, Inc. | 42,478 | US$1.87M | 0.19% |
| Tela Bio, Inc. | 2.14M | US$1.6M | 0.17% |
| Achieve Life Sciences, Inc. | 227K | US$1.48M | 0.15% |
| Fractyl Health, Inc. | 1.64M | US$1.3M | 0.14% |
| Connect Biopharma Holdings Limited | 545K | US$1.3M | 0.13% |
| Crescent Biopharma, Inc. | 59,104 | US$1.06M | 0.11% |
| Cellectar Biosciences, Inc. | 322K | US$894K | 0.09% |
| Foghorn Therapeutics Inc. | 45,975 | US$224K | 0.02% |
| Adagio Medical Holdings, Inc | 224K | US$146K | 0.02% |
| Nuvalent, Inc. | 0 | US$0 | 0.00% |
| Radiopharm Theranostics Limited | 0 | US$0 | 0.00% |
| Replimune Group, Inc. | 0 | US$0 | 0.00% |
| Scholar Rock Holding Corporation | 0 | US$0 | 0.00% |
| Surrozen, Inc. | 0 | US$0 | 0.00% |
| Zura Bio Limited | 0 | US$0 | 0.00% |
| Aardvark Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Annexon, Inc. | 0 | US$0 | 0.00% |
| Ascendis Pharma A/s | 0 | US$0 | 0.00% |
| Celldex Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Cg Oncology, Inc. | 0 | US$0 | 0.00% |
| Climb Bio, Inc. | 0 | US$0 | 0.00% |
| Compass Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Cytokinetics, Incorporated | 0 | US$0 | 0.00% |
| Edgewise Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Fulcrum Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Generate Biomedicines, Inc. | 0 | US$0 | 0.00% |
| Kalvista Pharmaceuticals, Inc. | 0 | US$0 | 0.00% |
| Monopar Therapeutics Inc. | 0 | US$0 | 0.00% |
| Neumora Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Nextcure, Inc. | 0 | US$0 | 0.00% |